News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Foody Joanne M.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/09/2023 |
4
| Foody Joanne M. (Chief Medical Officer) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 44,650 options to buy
@ $1.62, valued at
$72.3k
|
|
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/20/2023 |
4
| Foody Joanne M. (Chief Medical Officer) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Sold 3,808 shares
@ $1.7819, valued at
$6.8k
|
|
| 03/15/2023 |
4
| Foody Joanne M. (Chief Medical Officer) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 28,750 shares
@ $0
Granted 122,500 options to buy
@ $4.02, valued at
$492.5k
|
|
| 03/08/2023 |
4
| Foody Joanne M. (Chief Medical Officer) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Sold 3,884 shares
@ $5.065, valued at
$19.7k
|
|
| 01/19/2023 |
4
| Foody Joanne M. (Chief Medical Officer) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Sold 1,191 shares
@ $6.985, valued at
$8.3k
|
|
| 10/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2022 |
4
| Foody Joanne M. (Chief Medical Officer) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Sold 3,901 shares
@ $6.55, valued at
$25.6k
|
|
| 06/09/2022 |
4
| Foody Joanne M. (Chief Medical Officer) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 52,000 options to buy
@ $6.2, valued at
$322.4k
|
|
| 03/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2021 |
4
| Foody Joanne M. (Chief Medical Officer) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 22,450 shares
@ $0 |
|
| 07/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|